反应蛋白对结直肠癌的临床价值(3) - 诊断学理论与实践杂志社投稿_期刊论文发表|版面费|电话|编辑部- 诊断学理论与实践

来稿应自觉遵守国家有关著作权法律法规，不得侵犯他人版权或其他权利，如果出现问题作者文责自负，而且本刊将依法追究侵权行为给本刊造成的损失责任。本刊对录用稿有修改、删节权。经本刊通知进行修改的稿件或被采用的稿件，作者必须保证本刊的独立发表权。一、投稿方式： 1、请从我刊官网直接投稿。 2、请从我编辑部编辑的推广链接进入我刊投审稿系统进行投稿。二、稿件著作权： 1、投稿人保证其向我刊所投之作品是其本人或与他人合作创作之成果，或对所投作品拥有合法的著作权，无第三人对其作品提出可成立之权利主张。 2、投稿人保证向我刊所投之稿件，尚未在任何媒体上发表。 3、投稿人保证其作品不含有违反宪法、法律及损害社会公共利益之内容。 4、投稿人向我刊所投之作品不得同时向第三方投送，即不允许一稿多投。 5、投稿人授予我刊享有作品专有使用权的方式包括但不限于：通过网络向公众传播、复制、摘编、表演、播放、展览、发行、摄制电影、电视、录像制品、录制录音制品、制作数字化制品、改编、翻译、注释、编辑，以及出版、许可其他媒体、网站及单位转载、摘编、播放、录制、翻译、注释、编辑、改编、摄制。 6、第5条所述之网络是指通过我刊官网。 7、投稿人委托我刊声明，未经我方许可，任何网站、媒体、组织不得转载、摘编其作品。

反应蛋白对结直肠癌的临床价值(3)

作者:

关键词:

摘要：

[8]Delong E, Delong D, Clarke-Pearson D. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach[J]. Biometrics,1988,44(3):837-45.

[9]Schreuders E, Ruco A, Rabeneck L, et al. Colorectal cancer screening: a global overview of existing programmes[J]. Gut,2015,64(10):1637-49.

[10] Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation[J]. Nature,2008,454(7203):436-44.

[11] Kinoshita A, Onoda H, Imai N, et al. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma[J]. Annals of surgical oncology,2015,22(3):803-10.

[12] Qian B, Li J, Zhang H, et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis[J]. Nature,2011,475(7355):222-5.

[13] Nasr R, Salim Hammoud M, Nassar F, et al. Inflammatory Markers and MicroRNAs: The Backstage Actors Influencing Prognosis in Colorectal Cancer Patients[J]. International journal of molecular sciences,2018,19(7).

[14] Morris-Stiff G, Gomez D, Prasad K. C-reactive protein in liver cancer surgery[J]. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,2008,34(7):727-9.

[15] Hashimoto K, Ikeda Y, Korenaga D, et al. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma[J]. Cancer,2005,103(9):1856-64.

[16] Utsumi M, Aoki H, Nagahisa S, et al. Preoperative C-Reactive Protein/Albumin Ratio as a Predictive Factor for Gallbladder Carcinoma[J]. In vivo (Athens, Greece),2020,34(4):1901-1908.

[17] Primavesi F, Andreasi V, Hoogwater F, et al. A Preoperative Clinical Risk Score Including C-Reactive Protein Predicts Histological Tumor Characteristics and Patient Survival after Surgery for Sporadic Non-Functional Pancreatic Neuroendocrine Neoplasms: An International Multicenter Cohort Study[J]. Cancers,2020,12(5).

[18] Liu Y, Chen S, Zheng C, et al. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer[J]. BMC Cancer,2017,17(1):285.

[19] Sakai M, Sohda M, Saito H, et al. Comparative Analysis of Immunoinflammatory and Nutritional Measures in Surgically Resected Esophageal Cancer: A Single-center Retrospective Study[J]. In vivo (Athens, Greece),2020,34(2):881-887.

[20] Kim D, Oh S, Kwon H, et al. Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer[J]. BMC cancer,2009,9: 155.

[21] Ishizuka M, Nagata H, Takagi K, et al. Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen[J]. Ann Surg Oncol,2012,19(11):3422-31.

文章来源：《诊断学理论与实践》网址: http://www.zdxllysj.cn/qikandaodu/2021/0518/474.html